ဃုကွၢ် | Blue Cross MN

တၢ်ပာ်ဖျါ 2261 - 2270 လၢ 4296 အစၢတဖၣ်အကျါ

ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်

QP47-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization with Quantity Limit Criteria: Hereditary transthyretin-mediated (hATTR) Amyloidosis Neuropathy

ဖးအါထီၣ်

တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါယူၤ 12, 2019

ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်

QP57-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization Criteria: tafamidis

ဖးအါထီၣ်

တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါယူၤ 12, 2019

ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်

QP49-19 Pharmacy Benefit Exclusion for Proventil (albuterol sulfate) HFA and Proventil (albuterol sulfate) HFA Authorized Generic (AG)

ဖးအါထီၣ်

တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါယူၤ 12, 2019

ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်

QP54-19 Pharmacy Benefit Update – New Drug-Related Utilization Management Program: Opioid Immediate Release (IR) New to Therapy (NTT) Program

ဖးအါထီၣ်

တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါယူၤ 12, 2019

ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်

QP52-19 Pharmacy Benefit Exclusion for Cimzia, Elzonris, Gamifant, Kalbitor, Khapzory, leucovorin calcium, Nuzyra and Panzyga

ဖးအါထီၣ်

တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါယူၤ 12, 2019

ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်

QP53-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization with Quantity Limit Criteria: Neurotrophic Keratitis

ဖးအါထီၣ်

တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါယူၤ 12, 2019

ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်

QP59-19 eviCore Group Number List to be Removed

ဖးအါထီၣ်

တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါယူၤ 12, 2019

ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်

QP51-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization with Quantity Limit Criteria: Firdapse

ဖးအါထီၣ်

တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါယူၤ 12, 2019

ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်

QP45-19 Providers Need to Validate Members Coverage

ဖးအါထီၣ်

တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါယူၤ 12, 2019

ကသံၣ်ကသီပှၤဟ့ၣ်မၤစၢၤတၢ်

QP55-19 Authorization Attachment Tips on Availity Provider Portal

ဖးအါထီၣ်

တၢ်ရဲၣ်တၢ်ကျဲၤစးထီၣ်မူ၀ဲအမုၢ်နံၤမုၢ်သီ- လါယူၤ 12, 2019